News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
367,496 Results
Type
Article (23724)
Company Profile (47)
Press Release (343725)
Section
Business (111152)
Career Advice (1749)
Deals (22824)
Drug Delivery (69)
Drug Development (38115)
Employer Resources (63)
FDA (7866)
Job Trends (7645)
News (181434)
Policy (13887)
Tag
2024 BioCapital Digital (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (2)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
Academia (914)
Accelerated approval (1)
Adcomms (5)
Allergies (27)
Alliances (27241)
ALS (37)
Alzheimer's disease (446)
Antibody-drug conjugate (ADC) (57)
Approvals (7851)
Artificial intelligence (154)
Autoimmune disease (5)
Automation (7)
Bankruptcy (193)
Best Places to Work (5633)
BIOSECURE Act (14)
Biosimilars (30)
Biotechnology (39)
Bladder cancer (31)
Brain cancer (13)
Breast cancer (109)
Cancer (977)
Cardiovascular disease (71)
Career advice (1375)
Career pathing (16)
CAR-T (68)
Cell therapy (213)
Cervical cancer (6)
Clinical research (31088)
Collaboration (442)
Compensation (92)
Complete response letters (5)
COVID-19 (1159)
CRISPR (16)
C-suite (106)
Cystic fibrosis (48)
Data (933)
Decentralized trials (1)
Denatured (9)
Depression (18)
Diabetes (102)
Diagnostics (3546)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (14)
Drug discovery (64)
Drug pricing (44)
Drug shortages (21)
Duchenne muscular dystrophy (32)
Earnings (47373)
Editorial (22)
Employer branding (10)
Employer resources (56)
Events (49158)
Executive appointments (352)
FDA (8323)
Featured Employer (15)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (484)
Gene editing (56)
Generative AI (14)
Gene therapy (157)
GLP-1 (331)
Government (1737)
Grass and pollen (2)
Guidances (30)
Healthcare (8579)
Huntington's disease (13)
IgA nephropathy (5)
Immunology and inflammation (52)
Indications (7)
Infectious disease (1226)
Inflammatory bowel disease (59)
Inflation Reduction Act (6)
Influenza (25)
Intellectual property (49)
Interviews (307)
IPO (10893)
IRA (21)
Job creations (2199)
Job search strategy (1215)
Kidney cancer (6)
Labor market (11)
Layoffs (188)
Leadership (11)
Legal (2922)
Liver cancer (40)
Lung cancer (143)
Lymphoma (50)
Machine learning (2)
Management (21)
Manufacturing (216)
MASH (35)
Medical device (6440)
Medtech (6440)
Mergers & acquisitions (12293)
Metabolic disorders (312)
Multiple sclerosis (24)
NASH (8)
Neurodegenerative disease (39)
Neuropsychiatric disorders (11)
Neuroscience (641)
NextGen: Class of 2025 (3194)
Non-profit (1274)
Northern California (1151)
Now hiring (27)
Obesity (182)
Opinion (129)
Ovarian cancer (20)
Pain (25)
Pancreatic cancer (47)
Parkinson's disease (38)
Partnered (9)
Patents (78)
Patient recruitment (38)
Peanut (12)
People (29358)
Pharmaceutical (16)
Pharmacy benefit managers (10)
Phase I (10214)
Phase II (13877)
Phase III (10241)
Pipeline (643)
Podcasts (19)
Policy (57)
Postmarket research (883)
Preclinical (4021)
Press Release (40)
Prostate cancer (41)
Psychedelics (14)
Radiopharmaceuticals (162)
Rare diseases (153)
Real estate (3741)
Recruiting (25)
Regulatory (9985)
Reports (25)
Research institute (956)
Resumes & cover letters (325)
RNA editing (1)
RSV (14)
Schizophrenia (30)
Series A (104)
Series B (60)
Service/supplier (2)
Sickle cell disease (22)
Southern California (1061)
Special edition (12)
Sponsored (20)
Startups (2783)
State (2)
Stomach cancer (6)
Supply chain (40)
The Weekly (10)
United States (9967)
Vaccines (253)
Venture capitalists (33)
Webinars (4)
Weight loss (128)
Women's health (14)
Worklife (5)
Date
Today (90)
Last 7 days (418)
Last 30 days (1564)
Last 365 days (18908)
2025 (3117)
2024 (19215)
2023 (21292)
2022 (27784)
2021 (30329)
2020 (28566)
2019 (21365)
2018 (15789)
2017 (15692)
2016 (13320)
2015 (40731)
2014 (38854)
2013 (28122)
2012 (9115)
2011 (9711)
2010 (8172)
Location
Africa (561)
Alabama (29)
Alaska (3)
Arizona (68)
Arkansas (6)
Asia (24621)
Australia (3734)
California (2705)
Canada (984)
China (220)
Colorado (128)
Connecticut (155)
Delaware (42)
Europe (51814)
Florida (403)
Georgia (69)
Idaho (30)
Illinois (221)
India (8)
Indiana (128)
Iowa (4)
Japan (54)
Kansas (68)
Kentucky (2)
Louisiana (6)
Maine (38)
Maryland (289)
Massachusetts (1834)
Michigan (132)
Minnesota (152)
Mississippi (2)
Missouri (33)
Montana (8)
Nebraska (14)
Nevada (28)
New Hampshire (29)
New Jersey (778)
New Mexico (18)
New York (813)
North Carolina (491)
North Dakota (6)
Northern California (1151)
Ohio (91)
Oklahoma (7)
Oregon (8)
Pennsylvania (583)
Puerto Rico (2)
Rhode Island (14)
South America (710)
South Carolina (7)
Southern California (1061)
Tennessee (31)
Texas (420)
Utah (63)
Virginia (64)
Washington D.C. (28)
Washington State (235)
West Virginia (2)
Wisconsin (24)
367,496 Results for "check cap".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK), today announced financial results and provided a corporate update for the third quarter and nine months ended September 30, 2023.
November 27, 2023
·
16 min read
Press Releases
Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference
January 31, 2025
·
1 min read
Press Releases
Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference
January 31, 2025
·
2 min read
Press Releases
Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference
January 29, 2025
·
1 min read
Press Releases
EyePoint to Present at Guggenheim SMID Cap Biotech Conference
January 30, 2025
·
2 min read
Obesity
UK Pharmacies Regulator Wants Tighter Checks on Weight Loss Injections
Amid growing concern of the overuse and misuse of obesity drugs, the UK’s pharmacies regulator rolled out stricter guidelines for online pharmacies selling medicines including Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro.
February 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Arcutis to Present at the Guggenheim SMID Cap Biotech Conference
January 27, 2025
·
2 min read
Press Releases
Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference
January 31, 2025
·
1 min read
Press Releases
ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
January 30, 2025
·
1 min read
Press Releases
Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
January 30, 2025
·
1 min read
1 of 36,750
Next
